Team

Noam Wasserman
Director of USC’s Founder Central initiative
University of Southern California

Noam Wasserman is founding director of USC’s Founder Central initiative. Before returning home to L.A., he was a professor at University of Southern California for 13 years. His book, The Founder’s Dilemmas: Anticipating and Avoiding the Pitfalls That Can Sink a Startup, was an Amazon #1 bestseller in Management and won the Academy of Management’s Impact on Practice award. Noam created HBS’s most popular entrepreneurship elective, “Founder’s Dilemmas,” for which he won the Faculty Teaching Award. He also taught the course at Stanford Engineering, where he received a perfect teaching rating. Noam’s research has been published in top academic journals and national periodicals.

Aaron Lapat
Managing Partner
Park Square Executive Search

Aaron is a co-founder and Managing Partner of Park Square Executive Search. Aaron’s expertise is recruiting CEOs and functional leaders for private equity and venture capital-backed companies in the technology sector, including Internet, software and SaaS, as well as Cloud and Cloud Infrastructure companies. Aaron also has extensive exposure to the renewable energy market.

Prior to Park Square, Aaron was with J. Robert Scott, a global retained executive search firm. Aaron built and led the firm’s Technology practice and worked with leading investor groups and management teams in the US, Europe and Asia to build world-class organizations.

Aaron also co-founded CompStudy (www.compstudy.com) with Professor Noam Wasserman of Harvard Business School. Aaron continues to run CompStudy with Professor Wasserman and Aaron’s partners at Park Square. CompStudy is a comprehensive annual survey and analysis of board and executive compensation for privately held Technology and Life Sciences companies.

Aaron holds a B.A. in Anthropology as well as an M.B.A. from Boston University. He has served on the Board of Advisors of Stax, Inc., a privately-held management consulting and market research firm. He is a Board Member of Israel & Co., a not-for-profit that sends graduate students from the leading business, law, and public policy schools in the U.S. to Israel for multi-week educational programs.

Aaron and his wife Lauren have two children, Sophie and Sammy. In his spare time, Aaron plays tennis, runs and listens to music (often while running, but not while chewing gum). On the off days, he can be found stoking the embers of his VW-sized Texas BBQ, mixing up a homemade hot sauce, or trying to create the perfect play-list from his ever-expanding record (mp3) collection.

Erik Lundh
Managing Partner
Park Square Executive Search

Erik R. Lundh is a co-founder and Managing Partner at Park Square. He is based in Menlo Park, California and focuses nationally on the Life Sciences, Healthcare, and Cleantech industries.

Erik specializes in providing leadership consulting and talent advisory services to clients that are growth oriented in nature. He has more than 22 years of experience in the life sciences/healthcare industry and executive search. His clients have included global multinational corporations and early-stage companies alike. Erik’s proficiency in offering counsel and conducting engagements ranging from technical to operational roles stems from his own experience in both scientific and executive-level commercial functions within the life sciences industry.

Prior to co-founding Park Square, Erik was Managing Director, Life Sciences at J. Robert Scott, a global retained executive search firm. Previously, Erik was the Managing Partner with Heidrick & Struggles and Partner-in-Charge of the firm’s San Francisco office. Earlier, he was a Partner with another leading international executive search firm.

Before entering the search profession, Erik worked as an operator in roles spanning corporate strategy, business development, sales, marketing, and operations. While in industry, Erik held senior operating roles with companies such as Sentigen Holding Corp. (Nasdaq: SGHL), ACLARA BioSciences Inc. (Nasdaq: ACLA), SciQuest, Inc. (Nasdaq: SQST), and Qiagen Inc. (Nasdaq: QGEN).

Erik is an advisor to Spindletop Capital, and he currently serves on the Board of SentiSearch, Inc. Erik holds a bachelor’s degree in biological sciences from Santa Clara University.

Bruce Rychlik
Managing Partner
Park Square Executive Search

Bruce Rychlik is a co-founder and Managing Partner of Park Square Executive Search. With over twenty years in the search profession, Bruce Rychlik’s recruiting practice focuses on life sciences, specifically Chief Executive Officers as well as functional leaders—scientific, technical, clinical, financial and business development—at a national level. A majority of his searches involve venture-backed life science companies in the therapeutics, diagnostics and tools space.

Within life sciences, Bruce has also extensively recruited board members, venture capital professionals, and individuals for innovation/technology transfer initiatives at academic/research institutions. Throughout his career, he has also worked on numerous international recruiting projects throughout Asia, particularly Japan, as well as Europe.

Bruce is an Advisor to Convergence: The Life Sciences Leaders Forum, which hosts annual events in New England. He earned an M.B.A. from Boston University (1997) and a B.A. in Political Science from Dickinson College in Carlisle, Pennsylvania (1989). He lives with his wife Kristina, daughter Anna and sons Alexander and Robert in Acton, Massachusetts. Road cycling helps to fulfill his interests in exercise and nutrition, travel and the outdoors.

Mick Bain
Partner
WilmerHale

Mick Bain advises entrepreneurs, startups and high growth companies throughout their lifecycles. In addition, he represents venture capital firms, growth equity firms and strategic investors when making their portfolio investments. Recognized as a trusted advisor, he has helped hundreds of companies raise billions of dollars in seed, venture and strategic financing. His clients have spanned a vast array of technology and life sciences industries, including big data, clean technology, cybersecurity, digital advertising, digital media, e-commerce, FinTech, mobile and telecommunications, software, biotech and medical devices.

With more than two decades of experience, Mr. Bain advises his company clients on formation and governance issues, equity compensation matters, securities laws, international expansion and many other areas that are key to the growth of technology and life sciences companies. He also represents clients in complex corporate transactions including capital raising, M&A transactions, joint ventures, initial public offerings and other capital markets transactions. 

In addition, he has worked extensively with many venture capital and growth equity and strategic investors. These clients include North Bridge Venture Partners, Matrix Partners, MPM Capital and Spark Capital.

Kim Wethly
Partner
WilmerHale

Kimberly Wethly is the chair of the Tax Practice Group and a member of the FinTech Group.

Ms. Wethly has extensive experience in all aspects of executive compensation, including applicable tax, corporate securities and accounting issues. Ms. Wethly has represented both public and privately held companies' boards of directors and compensation committees and corporate executives. She advises the firm's corporate clients in connection with mergers and acquisitions, spin offs, formation, financings, restructurings and public offerings. Ms. Wethly's proficiency encompasses equity compensation, nonqualified deferred compensation, incentive plans, and executive, retention, severance and change-in-control agreements.

Learn more about Ms. Wethly's practice and how she can support your startup on WilmerHaleLaunch.com.

Publications

Recent publications by Ms. Wethly include "Best Practices for Option Grants by VC-Backed Companies,” published as a WilmerHale Email Alert and later published in Bloomberg Law Reports, October 2009; "Structuring Stock Options and Severance Payments after Section 409A," published in Spring 2006 edition of the Venture Capital Review; and "Stock Option Pricing Issues for Private Companies: Our Recommendations in Light of Section 409A and Recent AICPA Guidance," published as a WilmerHale Email Alert.

David D. Gammell
Partner
Co-Chair, Emerging Company Practice

David Gammell represents companies—including information technology, cleantech, fintech, healthcare IT, medical device, energy, life sciences, materials science and other high technology and entrepreneurial businesses—in complex corporate transactions throughout their lifecycle. As co-chair of WilmerHale's Emerging Company Practice, he partners with entrepreneurs, investors and startups to help clients navigate the legal issues, team dynamics and business challenges that the companies may encounter as they grow.

With nearly two decades of experience, Mr. Gammell has a substantial practice advising early stage companies on formation and founders issues, equity structure and incentives and intellectual property strategy. He also represents clients in complex corporate transactions including licensing, technology transfer and strategic alliances, angel and venture capital financings, and mergers and acquisitions. Some of Mr. Gammell's recent venture-backed clients include: Abine, Cannonball, Flywire (formerly known as peerTransfer), Foro Energy, Nanigans and SnapApp.

In addition, Mr. Gammell represents several leading national and international venture capital funds, private equity funds and angel investors in a range of transactions. Recently, he represented Accomplice, Bain Capital Ventures and Spark Capital in financing transactions.

Mr. Gammell maintains an active practice representing pro bono clients and social entrepreneurs. One of his social entrepreneurship clients is Andela, a startup currently building a network of top tier computer science education programs across Africa.

Prior to beginning his legal career, Mr. Gammell was a nuclear engineer and officer in the United States Navy.

Lia Der Marderosian
Partner
Co-Chair, Corporate Practice Group

Lia Der Marderosian is a leading corporate lawyer and trusted business advisor who helps clients navigate complex issues unique to the life sciences industry. She leads the firm's Corporate Practice Group as co-chair and has developed an exceptional practice representing life sciences companies—including biotechnology, pharmaceutical and healthcare companies—in a variety of corporate and securities law matters for nearly 20 years.

Ms. Der Marderosian deeply enjoys learning about, and working with, life sciences companies to understand the complexities of their businesses. She provides ongoing counsel to boards, management teams and in-house counsel on general corporate matters, including formation, corporate governance, commercial transactions, financings and SEC compliance matters.

By combining strategic business advice and experienced legal counsel, she provides practical, solutions-oriented advice during all stages of the company lifecycle. Ms. Der Marderosian has extensive experience in structuring and negotiating transactions that will successfully advance a product from the discovery phase to commercialization. She has advised on numerous venture capital and strategic financings, initial public offerings, follow-on and other offerings, PIPEs and mergers and acquisitions.

In addition, Ms. Der Marderosian has a robust startup practice and has advised numerous entrepreneurs and emerging companies from formation to exit. Learn more about Ms. Der Marderosian's practice and how she can support your startup on WilmerHaleLaunch.com.